Aroa Biosurgery Limited
AROAF
$0.35
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 88.87% | 88.26% | 47.21% | 48.89% | -112.05% |
| Total Depreciation and Amortization | -7.88% | -2.83% | -- | -- | 110.17% |
| Total Amortization of Deferred Charges | 546.94% | 582.07% | -- | -- | -- |
| Total Other Non-Cash Items | -22.42% | -18.16% | -59.97% | -54.91% | -40.44% |
| Change in Net Operating Assets | -5.18% | -10.95% | -- | -- | 34.15% |
| Cash from Operations | 2,979.30% | 3,135.71% | 32.61% | 34.75% | -108.86% |
| Capital Expenditure | 51.16% | 48.49% | 25.09% | 27.47% | 63.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -165.14% | -168.71% | 134.02% | 126.57% | 504.45% |
| Cash from Investing | -184.73% | -189.38% | 307.44% | 294.46% | 453.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -45.07% | -45.07% | -27.79% | -27.79% | -8.90% |
| Issuance of Common Stock | -- | -- | -72.41% | -72.41% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -31.25% | -31.25% | -6.99% | -6.99% | -215.79% |
| Cash from Financing | -45.77% | -53.81% | -31.03% | -26.88% | -128.04% |
| Foreign Exchange rate Adjustments | 446.67% | 465.84% | -142.55% | -141.22% | 88.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -168.70% | -172.47% | 137.60% | 136.40% | 400.95% |